The Diabetes-Prone NZO/Hl Strain. II. Pancreatic Immunopathology

We report the first combined light and electron microscopic analysis of the pancreas during the development of type 2 diabetes in the New Zealand Obese (NZO) mouse. As in most other polygenic rodent models of type 2 diabetes, hyperglycemia associated with beta cell destruction is male sex-limited. Increasing degrees of hyperinsulinemia and transition to diabetes were clearly reflected by the islet volume fraction, by the beta cell granulation state, and by ultrastructural changes, primarily of the endoplasmic reticulum. One of the unusual histopathologic features of NZO mice of both sexes was the presence of B-lymphocyte enriched leukocytic aggregates in the pancreas. Immunocytochemical analysis of the pancreas of 52-week-old diabetic males indicated enrichment for CD19+ B lymphocytes. Staining of adjacent sections for CD3 and CD5 indicated CD5 coexpression on some of the CD19+ cells, suggesting the presence of the B1-B subset associated with generation of natural autoantibodies in other autoimmune-prone New Zealand mouse strains. In addition, plasma cells in peri-insular leukocytic infiltrates were identified by electron microscopy. Hence, although autoimmunity has previously proven to be a secondary manifestation of beta cell destruction in most rodent models of type 2 diabetes, the present observations suggest that B lymphocyte function, in association with male gender, may contribute to the development of insulin resistance and chronic hyperglycemia in the NZO model.

[1]  E. Leiter,et al.  The Diabetes-Prone NZO/HlLt Strain. I. Immunophenotypic Comparison to the Related NZB/BlNJ and NZW/LacJ Strains , 2002, Laboratory Investigation.

[2]  S. Ikehara,et al.  B cells are selectively associated with thymic cortical but not medullary pathology in NZB mice. , 2001, Journal of autoimmunity.

[3]  J. Kearney,et al.  B1 cells: similarities and differences with other B cell subsets. , 2001, Current opinion in immunology.

[4]  B. Taylor,et al.  Multiple obesity QTLs identified in an intercross between the NZO (New Zealand obese) and the SM (small) mouse strains , 2001, Mammalian Genome.

[5]  B. Yandell,et al.  Genetic obesity unmasks nonlinear interactions between murine type 2 diabetes susceptibility loci. , 2000, Diabetes.

[6]  G Churchill,et al.  Maternal environment and genotype interact to establish diabesity in mice. , 2000, Genome research.

[7]  M. Rewers,et al.  Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Y. Kido,et al.  Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. , 2000, The Journal of clinical investigation.

[9]  C. Vigouroux,et al.  Antiinsulin receptor autoantibodies induce insulin receptors to constitutively associate with insulin receptor substrate-1 and -2 and cause severe cell resistance to both insulin and insulin-like growth factor I. , 1999, The Journal of clinical endocrinology and metabolism.

[10]  W. Suzuki,et al.  A new mouse model of spontaneous diabetes derived from ddY strain. , 1999, Experimental animals.

[11]  E. Leiter,et al.  NIDDM Genes in Mice: Deleterious Synergism by Both Parental Genomes Contributes to Diabetogenic Thresholds , 1998, Diabetes.

[12]  C. Kahn,et al.  Development of a Novel Polygenic Model of NIDDM in Mice Heterozygous for IR and IRS-1 Null Alleles , 1997, Cell.

[13]  E. Leiter,et al.  Effect of immunodeficiency on diabetogenesis in genetically diabetic (db/db) mice. , 1987, Journal of immunology.

[14]  C. Gordon,et al.  Obesity, Hyperinsulinaemia and Hyperplasia of the Pancreatic Islets in Ageing (C3H/HeJ x C57BI/6J) F1 Hybrid Mice , 1986, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[15]  A. Attallah,et al.  Immune abnormalities in the diabetic New Zealand obese (NZO) mouse: insulin treatment partially suppresses splenic hyperactivity measured by flow cytometric analysis. , 1985, Clinical immunology and immunopathology.

[16]  Leiter Eh.  Type C retrovirus production by pancreatic beta cells. Association with accelerated pathogenesis in C3H-db/db ("Diabetes") mice. , 1985 .

[17]  T. Seemayer,et al.  Pancreatic cellular infiltrates in autoimmune-prone New Zealand Black mice , 1984, Diabetologia.

[18]  H. Morgenstern,et al.  Epidemiologic Research: Principles and Quantitative Methods. , 1983 .

[19]  H. Sato,et al.  Enhancing effect of H-2-linked NZW gene(s) on the autoimmune traits of (NZB X NZW)F1 mice , 1983, The Journal of experimental medicine.

[20]  A. Steinberg,et al.  Diabetes is Associated with Autoimmunity in the New Zealand Obese (NZO) Mouse , 1980, Diabetes.

[21]  L. Harrison,et al.  A possible mechanism for insulin resistance and hyperglycaemia in NZO mice , 1979, Nature.

[22]  A. Theofilopoulos,et al.  Association of circulating retroviral gp70-anti-gp70 immune complexes with murine systemic lupus erythematosus , 1979, The Journal of experimental medicine.

[23]  M. Hayat,et al.  Principles and Techniques of Electron Microscopy: Biological Applications , 1975 .

[24]  R. Gates,et al.  Return to normal of blood-glucose, plasma-insulin, and weight gain in New Zealand obese mice after implantation of islets of Langerhans. , 1972, Lancet.

[25]  Hitoshi Ikeda,et al.  KK mouse. , 1994, Diabetes research and clinical practice.

[26]  R. Gates,et al.  The ability of pancreatic polypeptides (APP and BPP) to return to normal the hyperglycaemia, hyperinsulinaemia and weight gain of New Zealand obese mice. , 1977, Hormone research.

[27]  A. Spurr.  A low-viscosity epoxy resin embedding medium for electron microscopy. , 1969, Journal of ultrastructure research.